Natural Killer Cells in Multiple Sclerosis: Dual Roles in Neuroinflammation and Neuroprotection
Abstract
Multiple Sclerosis (MS) is a chronic, immune-mediated neurological disorder characterized by demyelination and neurodegeneration within the central nervous system (CNS). Among the diverse immune cells involved in the disease's pathophysiology, Natural Killer (NK) cells have garnered increasing interest due to their complex and seemingly contradictory roles. Traditionally recognized for their cytotoxic function against infected and transformed cells, NK cells are now understood to exert both pro-inflammatory and regulatory effects in MS. This review explores the dual roles of NK cells in MS, highlighting their contribution to neuroinflammation and potential in mediating neuroprotection. On one hand, NK cells can exacerbate disease activity by promoting the destruction of oligodendrocytes and releasing inflammatory cytokines such as IFN-γ and TNF-α. On the other hand, subsets of NK cells particularly the CD56^bright population—demonstrate immunoregulatory properties by modulating dendritic cell function and suppressing autoreactive T cells, thereby contributing to CNS immune homeostasis. We also discuss how NK cell frequency, phenotype, and function are altered in MS patients, and how current disease-modifying therapies impact these cells. Understanding the conditions under which NK cells shift from pathogenic to protective roles may unlock new therapeutic avenues aimed at enhancing their regulatory capacity while minimizing their harmful effects. Ultimately, targeting NK cell responses holds promise for more precise immunomodulation in MS, potentially balancing disease control with CNS preservation.
References
Ahmadi, Z. Fallah Vastani, M. Abounoori, M. Azizi et al., "The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies," 2022.
J. Beliën, A. Goris, and P. Matthys, "Natural Killer Cells in Multiple Sclerosis: Entering the Stage," 2022.
A. Ahmadi, Z. Fallah Vastani, M. Abounoori, et al., "The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies," Health Science, vol. XX, no. XX, pp. XX-XX, 2022.
J. Beliën, A. Goris, and P. Matthys, "Natural killer cells in multiple sclerosis: entering the stage," Frontiers in Immunology, 2022.
P. Theodosis-Nobelos and E. A. Rekka, "The multiple sclerosis modulatory potential of natural multi-targeting antioxidants," Molecules, 2022.
C. Rodriguez-Mogeda and C. M. J. van Ansenwoude, "The role of CD56bright NK cells in neurodegenerative disorders," *Journal of Neuroinflammation*, 2024.
L. Eva, H. Pleș, R. A. Covache-Busuioc, and L. A. Glavan, "A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments," Biomedicines, 2023.
M. K. Zarobkiewicz, I. Morawska, A. Michalski, "NKT and NKT-like cells in autoimmune neuroinflammatory diseases—multiple sclerosis, myasthenia gravis and guillain-barre syndrome," *International Journal of …*, 2021.
Z. Ning, Y. Liu, D. Guo, W. J. Lin et al., "Natural killer cells in the central nervous system," Cell Communication and Signaling, 2023.
Z. Gong, Y. Liu, F. Ding, L. Ba et al., "Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study," Frontiers in Neuroscience, 2022.
K. E. Attfield, L. T. Jensen, M. Kaufmann, et al., "The immunology of multiple sclerosis," *Nature Reviews*, vol. 22, no. 5, 2022.
AJ Highton, IS Schuster, MA Degli-Esposti, "The role of natural killer cells in liver inflammation," Seminars in…, vol. 2021, Springer.
S. Kumar Sarkar, A. M. L. Willson, and M. A. Jordan, "The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis," 2024.
U. C. Kucuksezer, E. Aktas Cetin, and F. Esen, "The role of natural killer cells in autoimmune diseases," Frontiers in…, vol. 2021.
S. Palmeri, M. Ponzano, F. Ivaldi, A. Signori, C. Lapucci, "... (NK) cells on immune reconstitution, and their potential as a biomarker of disease activity, in alemtuzumab-treated patients with relapsing remitting multiple sclerosis ...," CNS Drugs, vol. 2022, Springer.
Y. Yang and J. Day, "Natural killer cells in inflammatory autoimmune diseases," *Clinical &*, vol. 2021, Wiley Online Library.
M. Liu, S. Liang, and C. Zhang, "NK cells in autoimmune diseases: protective or pathogenic?," Frontiers in Immunology, 2021.
Q. Zhang, J. Lin, M. Yang, Z. Li, M. Zhang, and B. Bu, "Therapeutic potential of natural killer cells in neuroimmunological diseases," Biomedicine & …, 2024.
N. M. Shukla, T. E. Lotze, and E. Muscal, "Inflammatory diseases of the central nervous system," Neurologic Clinics, 2021.
S. Haase and R. A. Linker, "Inflammation in multiple sclerosis," Advances in Neurological Disorders, vol. 2021.
M. T. Cencioni, A. Genchi, G. Brittain, T. I. de Silva, "Immune reconstitution following autologous hematopoietic stem cell transplantation for multiple sclerosis: A review on behalf of the EBMT autoimmune diseases …," Frontiers in …, 2022.
L. Zeng, G. Yu, K. Yang, W. Xiang, and J. Li, “Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Multiple Sclerosis),” Stem Cells, vol. 2022, Wiley Online Library.
G. Frazzei, R. F. van Vollenhoven, B. A. de Jong, et al., "Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes," *Frontiers in …*, 2022.
T. Brummer, T. Ruck, S. G. Meuth, "Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders," in *Journal of Neurological Sciences*, vol. XX, no. XX, pp. XX-XX, 2021.
E. Y. Rad, S. Saboori, T. G. Tektonidis, S. Simpson-Yap, and others, "A systematic review and meta-analysis of Dietary Inflammatory Index and the likelihood of multiple sclerosis/demyelinating autoimmune disease," *Clinical Nutrition*, vol. 2024, Elsevier.
V. Ramaglia, O. Rojas, I. Naouar, "The ins and outs of central nervous system inflammation—lessons learned from multiple sclerosis," Annual Review of…, vol. 2021.
M. D. Kornberg and P. A. Calabresi, "Multiple sclerosis and other acquired demyelinating diseases of the central nervous system," Cold Spring Harbor Perspectives, 2025.
A. Kalinowska-Łyszczarz and Y. Guo, "Update on pathology of central nervous system inflammatory demyelinating diseases," Neurologia i…, 2022.
Q. Zhang, Z. Chen, K. Zhang, J. Zhu, "FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis," CNS Neuroscience & Biobehavioral Reviews, vol. 2023, Wiley Online Library.
K. Al Johani, M. Fudah, M. Al-Zahrani, H. Abed, "Multiple sclerosis—a demyelinating disorder and its dental considerations—a literature review with own case report," Brain Sciences, 2023.
Lateef, Diyar, Nesreen Nasser, and Osama Mohsein. "The relationships between Aplein, Vaspin and thyroid hormone levels in obese diabetic and non-diabetic women." Journal of Experimental and Clinical Medicine 41.2 (2024): 239-245.
V. G. Coutinho Costa and S. E. S. Araújo, "Central nervous system demyelinating diseases: Glial cells at the hub of pathology," Frontiers in…, 2023.
K. Maiese, "Novel insights for multiple sclerosis and demyelinating disorders with apoptosis, autophagy, FoxO, and mTOR," Current Neurovascular Research, 2021.
A. L. Fymat, "Multiple sclerosis: I. Symptomatology and etiology," J Neurol Psychol Res, 2023.
N. K. Wolf, D. U. Kissiov, and D. H. Raulet, "Roles of natural killer cells in immunity to cancer, and applications to immunotherapy," Nature Reviews Immunology, 2023.
Hamad, Anas Abdullah, Hamssa Majid Mustafa, and Osama A. Mohsein. "Detection of the levels of immune cytokines (IL4, IL5, TNF-α) in school-age and preschoolers with an Ascaris lumbricoides infection." Journal of Parasitic Diseases 48.4 (2024): 782-787.
A. Brauning, M. Rae, G. Zhu, E. Fulton, T. D. Admasu, "Aging of the immune system: focus on natural killer cells phenotype and functions," Cells, vol. 2022.
D. Masmoudi, M. Villalba, and C. Alix-Panabières, "Natural killer cells: the immune frontline against circulating tumor cells," Journal of Experimental & …, 2025.
M. M. Berrien-Elliott, M. T. Jacobs, and T. A. Fehniger, "Allogeneic natural killer cell therapy," Blood, 2023.
Faisal, Ahmed Nassir, Abbas Mohsin Abbas, and Osama A. Mohsein. "Histological and Cytokine-Based Biomarkers in the Early Diagnosis of Cancer: Biomarker Berbasis Histologi dan Sitokin dalam Diagnosis Dini Kanker." Indonesian Journal on Health Science and Medicine 2.2 (2025): 10-21070.
J. Chu, F. Gao, M. Yan, S. Zhao, Z. Yan, and B. Shi, "Natural killer cells: a promising immunotherapy for cancer," *Journal of Translational Medicine*, vol. 20, no. 1, 2022.
E. Vivier, L. Rebuffet, E. Narni-Mancinelli, S. Cornen, "Natural killer cell therapies," Nature, 2024.
X. Wei and X. Yang, "The central role of natural killer cells in preeclampsia," Frontiers in Immunology, 2023.
Hilo, Zainab Qassim Mohammed, Aswan Mahmood, and Osama A. Mohsein. "Genomic Insights into Staphylococcus aureus: Mechanisms of Antibiotic Resistance and Virulence Gene Expression." European Journal of Ecology, Biology and Agriculture 1.5 (2024): 29-48.
A. Bar-Or and R. Li, "Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances," The Lancet Neurology, 2021.
R. Amoriello, C. Memo, L. Ballerini, and C. Ballerini, "The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology," Molecular Brain, 2024.
G. La Rosa, M. S. Lonardo, N. Cacciapuoti, et al., "Dietary polyphenols, microbiome, and multiple sclerosis: From molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence," *International Journal of …*, 2023.
K. Maciak, A. Dziedzic, and J. Saluk, "Possible role of the NLRP3 inflammasome and the gut–brain axis in multiple sclerosis‐related depression," The FASEB Journal, 2023.
Abdulmuttaleb, Nabaa Azhar, Mohammed Qasim Mohammed, and Osama Akram Mohsein. "Exploring the Connection Between Inflammatory Cytokines, Hypertension, and Diabetes in Angina Patients." Cytokines 14.15 (2024): 16.
M. Timmer, "The Dual Role of TNFRs in Multiple Sclerosis Treatment. Neuroprotection, Therapeutic Strategies, and Future Perspectives," 2024.
C. Prado, A. A. Herrada, D. Hevia, and L. G. Goiry, "Role of innate immune cells in multiple sclerosis," Frontiers in …, 2025.
E. Yazdanpanah, S. Dadfar, A. Shadab, et al., "Berberine: A natural modulator of immune cells in multiple sclerosis," Immunity, vol. 2024, Wiley Online Library.
N. Hijal, M. Fouani, and B. Awada, "Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis," Frontiers in Neurology, 2024.
Abdulmuttaleb, Nabaa Azhar, Mohammed Qasim Mohammed, and Osama Akram Mohsein. "The impact of adipocytokines on thyroid function and obesity: A narrative review." development 8: 9.
G. Fadda, E. P. Flanagan, L. Cacciaguerra, et al., "Myelitis features and outcomes in CNS demyelinating disorders: comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD," Frontiers in ..., vol. 2022.
J. Basak and I. Majsterek, "miRNA‐Dependent CD4+ T Cell Differentiation in the Pathogenesis of Multiple Sclerosis," Multiple sclerosis international, 2021.
M. A. Dias de Sousa, C. S. Desidério, J. da Silva Catarino, et al., "Role of Cytokines, Chemokines and IFN-γ+ IL-17+ Double-Positive CD4+ T Cells in Patients with Multiple Sclerosis," Biomedicines, 2022.
Naif, Nabaa Hassan, et al. "The Impact of Inflammatory and Adipokine Biomarkers on Breast Cancer Progression and Patient Outcomes." Bulletin of Pharmaceutical Sciences Assiut University 48.1 (2025): 511-522.
M. Eschborn, T. Schneider-Hohendorf, and others, "Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound," *Proceedings of the National Academy of Sciences*, vol. 2023.
Faqri, A. M. A., et al. "The Role of Cytokines in Autoimmune Diseases: Pathogenesis and Therapeutic Implications." Central Asian Journal of Medical and Natural Science 6.3 (2025): 852-873.
R. Haque, Y. Kim, K. Park, H. Jang, S. Y. Kim, "Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis," *Clinical & Experimental Immunology*, vol. 2021.
R. Gomez-Bris, A. Saez, B. Herrero-Fernandez, "CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease," *International Journal of...*, 2023.
A. Schnell, D. R. Littman, and V. K. Kuchroo, "TH17 cell heterogeneity and its role in tissue inflammation," Nature immunology, 2023.
J. Zhao, Q. Lu, Y. Liu, Z. Shi, L. Hu, and Z. Zeng, "Th17 cells in inflammatory bowel disease: cytokines, plasticity, and therapies," *Journal of …*, vol. 2021, Wiley Online Library.
Lafta Hassan, Z., A. Gayed Al-Ani, A., Mahmoud Hussain, A. and A. Mohsein, O. (2025) “Metabolic Syndrome and Its Biochemical Implications: Insights into Early Detection”, Central Asian Journal of Medical and Natural Science, 6(3), pp. 1101-1126. doi: 10.17605/cajmns.v6i3.2812.
V. Perri, M. A. Zingaropoli, P. Pasculli, F. Ciccone, et al., "The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis," Biology, 2024.
N. Sadeghi Hassanabadi, B. Broux, S. Marinović, and others, "Innate lymphoid cells-neglected players in multiple sclerosis," *Frontiers in Immunology*, vol. 2022.
L. Lapides, I. Varga, M. Csöbönyeiová, M. Klein, "The neglected uterine NK cells/hamperl cells/endometrial stromal granular cell, or K cells: a narrative review from history through histology and to medical …," *International Journal of …*, 2023.
Hadi, Qabas Neamah, et al. "The Genetic Basis of Biofilm Formation in Acinetobacter baumannii and Its Clinical Implications." History 6.2 (2025): 745-761.
M. Chambon and A. Koenig, "NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection," Transplant International, 2024.
M. M. Elanany, D. Mostafa, and N. M. Hamdy, "Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer," Life sciences, 2023.
Y. Zhou, L. Cheng, L. Liu, and X. Li, "NK cells are never alone: crosstalk and communication in tumour microenvironments," Molecular Cancer, 2023.
Y. Chu, M. Lamb, M. S. Cairo, and D. A. Lee, "The future of natural killer cell immunotherapy for B cell non-Hodgkin lymphoma (B Cell NHL)," Current Treatment Options in Oncology, vol. 23, no. 5, pp. 1-12, 2022.
Faqri, A. M. A., et al. "The Role of Cytokines in Autoimmune Diseases: Pathogenesis and Therapeutic Implications." Central Asian Journal of Medical and Natural Science 6.3 (2025): 852-873.
M. Tarannum and R. Romee, "Cytokine-induced memory-like natural killer cells for cancer immunotherapy," Stem Cell Research & Therapy, 2021.
A. Letafati, O. S. Ardekani, M. Naderisemiromi, and M. Norouzi, "Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications," Virology Journal, 2024.
M. R. Lordo, A. R. Stiff, C. C. Oakes, "Effects of epigenetic therapy on natural killer cell function and development in hematologic malignancy," *Journal of Leukocyte Biology*, 2023.
Y. Shi, D. Hao, H. Qian, and Z. Tao, "Natural killer cell-based cancer immunotherapy: from basics to clinical trials," Experimental Hematology & Oncology, 2024.
T. Iyoda, S. Yamasaki, S. Ueda, K. Shimizu et al., "Natural killer T and natural killer cell-based immunotherapy strategies targeting cancer," Biomolecules, 2023.
G. H. Ran, Y. Q. Lin, L. Tian, T. Zhang, D. M. Yan, et al., "Natural killer cell homing and trafficking in tissues and tumors: from biology to application," *Nature Reviews Immunology and Targeted Therapy*, 2022.
Taha, Ruqayah Qubtan, et al. "Unraveling the Genomic Landscape of Multidrug-Resistant Klebsiella pneumoniae: A Focus on Resistance Islands." (2025).
N. A. Chrysanthakopoulos and E. Vryzaki, "The role of cytokines, chemokines and NFkB in inflammation and cancer," J Case Rep Med Hist, 2023.
M. J. Shannon and E. M. Mace, "Natural killer cell integrins and their functions in tissue residency," Frontiers in Immunology, 2021.
G. Harvanová and S. Duranková, "The role of cytokines and chemokines in the inflammatory response," Alergologia Polska-Polish, 2023.
Abdulhussien, Adeeb Abdulally, Zainab M. Farhan, and Osama A. Mohsein. "The Clinico-Pathological Role of Horizontal Gene Transfer in the Ability of Pseudomonas Aeruginosa to Cause Disease in Lung Tissue." European Journal of Medical and Health Research 3.1 (2025): 27-34.
S. Rodríguez-Lorenzo and L. van Olst, "Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis," *Elife*, 2022.
J. Ruder, J. Rex, S. Obahor, M. J. Docampo, et al., "NK cells and innate-like T cells after autologous hematopoietic stem cell transplantation in multiple sclerosis," Frontiers in Immunology, vol. 12, 2021.
X. Zheng, Z. Hou, Y. Qian, Y. Zhang, Q. Cui, and X. Wang, "Tumors evade immune cytotoxicity by altering the surface topology of NK cells," *Nature*, vol. 2023.
L. A Fogel, W. M Yokoyama, and A. R French, "Natural killer cells in human autoimmune disorders," 2013.
N. Saez-Calveras and O. Stuve, "The role of the complement system in Multiple Sclerosis: A review," Frontiers in immunology, 2022.
O. G. Thomas and T. Olsson, "Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis," Frontiers in immunology, 2023.
D. Esser, L. Müller-Miny, M. Heming, M. Paunovic, et al., "Activated αβ T-and reduced mucosa-associated invariant T cells in LGI1-and CASPR2-encephalitis," Brain, 2025.
Y. Mi, J. Han, J. Zhu, and T. Jin, "Role of the PD‐1/PD‐L1 signaling in multiple sclerosis and experimental autoimmune encephalomyelitis: recent insights and future directions," Molecular neurobiology, 2021.
Hussein, Abdulhakeem Dahham, et al. "Emerging biomarkers in cancer detection and prognosis: A comprehensive review." International Journal of Immunology 7.1 (2025): 01-12.
D. Y. Kamyan, "… THE ROLE OF NATURAL KILLER (NK) CELLS IN OZANIMOD-MEDIATED REMISSION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) IN C57BL …," 2022.
S. Dhaiban, M. Al-Ani, N. M. Elemam, M. H. Al-Aawad, "Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis," Sci, vol. 2021.
M. M. D. Mader, A. Napole, D. Wu, M. Atkins, A. Scavetti, et al., "Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis," *Nature*, 2024.
E. Gianchecchi, D. V. Delfino, and A. Fierabracci, "Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases?," Frontiers in immunology, 2021.
Adnan, Azher, Zainab Mohammed Farhan, and Osama A. Mohsein. "Understanding the link between diabetes mellitus and fatty liver disease: A narrative review." Int J Chem Stud 12.4 (2024): 40-48.
J. Krämer, A. Bar-Or, T. J. Turner, and H. Wiendl, "Bruton tyrosine kinase inhibitors for multiple sclerosis," Nature Reviews Neurology, 2023.
L. Zhao, W. Shi, F. Hu, X. Song, Z. Cheng, "… of microplastics induced inflammation in the liver tissues of C57BL/6J mice through polarization of macrophages and increased infiltration of natural killer cells," *Journal of Hazardous Materials*, vol. 2021, Elsevier.
Nasser, N. A., et al. "The levels of prostate specific antigen and leptin hormone in patients with prostate cancer. S." Asian J. Life Sci 13 (2025): 1-7.
M. Mimpen, A. H. Muris, L. Rolf, O. Gerlach, "Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis," *European Journal of …*, vol. XX, no. YY, pp. ZZ-ZZ, 2021.
A. Vojdani, S. Koksoy, E. Vojdani, M. Engelman, and C. Benzvi, "Natural killer cells and cytotoxic T cells: complementary partners against microorganisms and cancer," Microorganisms, 2024.
Y. A. Gebru, H. Gupta, H. S. Kim, J. A. Eom, G. H. Kwon, "T cell subsets and natural killer cells in the pathogenesis of nonalcoholic fatty liver disease," *International Journal of …*, 2021.
Y. Yang, F. Yang, Z. Huang, Y. Li, H. Shi, and Q. Sun, "T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems," *Frontiers in …*, 2023.
O. Kyrysyuk and K. W. Wucherpfennig, "Designing cancer immunotherapies that engage T cells and NK cells," Annual review of immunology, 2023.
W. Yu, Q. Lei, L. Yang, G. Qin, S. Liu, and D. Wang, "Contradictory roles of lipid metabolism in immune response within the tumor microenvironment," *Journal of Hematology & Oncology*, vol. 14, no. 1, 2021.
WN Jin, K Shi, W He, JH Sun, L Van Kaer, FD Shi, "Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition," *Nature*, vol. 2021.
B. Dou, S. Li, L. Wei, L. Wang, S. Zhu, Z. Wang, and Z. Ke, "Astragaloside IV suppresses post-ischemic natural killer cell infiltration and activation in the brain: involvement of histone deacetylase inhibition," *Frontiers of …*, vol. 2021, Springer.
C. S. Boddupalli, S. Nair, G. Belinsky, J. Gans, E. Teeple, et al., "Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy," *Elife*, 2022.
R. Xiao, S. Ali, M. A. Caligiuri, and L. Cao, "Enhancing effects of environmental enrichment on the functions of natural killer cells in mice," Frontiers in immunology, 2021.
P. Wendel, L. M. Reindl, T. Bexte, L. Künnemeyer, et al., "Arming immune cells for battle: a brief journey through the advancements of T and NK cell immunotherapy," Cancers, vol. 13, no. 21, pp. 5432, 2021.
P. Olejnik, Z. Roszkowska, S. Adamus, "Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects," *Pharmacological Research*, vol. 2024, Springer.
M. T. Cencioni, M. Mattoscio, R. Magliozzi, et al., "B cells in multiple sclerosis—from targeted depletion to immune reconstitution therapies," *Nature Reviews*, vol. 21, no. 1, pp. 54-68, 2021.
C. Bridel, "BIOMARKERS OF DISEASE PROGRESSION IN MULTIPLE SCLEROSIS: TOWARDS MEASURING THE FOREST BEHIND THE TREE," access.archive-ouverte.unige.ch, .
P. Nishit, V. S. Kumar, T. Ishi, A. Lokesh, "Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision …," Metabolic Brain Disorders, vol. 2022.
P. P. Maldonado, C. Guevara, M. A. Olesen, J. A. Orellana, "Neurodegeneration in multiple sclerosis: the role of Nrf2-dependent pathways," Antioxidants, 2022.
M. Behrens, M. Comabella, and J. D. Lünemann, "EBV-specific T-cell immunity: relevance for multiple sclerosis," Frontiers in Immunology, 2024.
I. Stolzer, E. Scherer, P. Süß, V. Rothhammer, "Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration," *International Journal of …*, 2023.
R. Li, H. Li, X. Yang, H. Hu et al., "Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis," Frontiers in Immunology, 2022.
E. F. McKinney, I. Cuthbertson, K. M. Harris, et al., "A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis," *Nature*, 2021.
A. E. Lovett-Racke, Y. Yang, Y. Liu, M. Gormley, et al., "B cell depletion changes the immune cell profile in multiple sclerosis patients: one-year report," *Journal of …*, 2021.
R. Kölliker-Frers and L. Udovin, "Neuroinflammation: an integrating overview of reactive‐Neuroimmune cell interactions in health and disease," Mediators of Inflammation, vol. 2021, 2021.
K. Wang, Z. Sun, Q. Shao, Z. Wang, H. Zhang, "Modulation of double-negative T cells by Huang-Lian-Jie-Du Decoction attenuates neuroinflammation in ischemic stroke: insights from single-cell transcriptomics," Frontiers in ..., 2025.
M. Andreadou, F. Ingelfinger, D. De Feo, et al., "IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice," *Nature*, 2023.
Q. Zhang, G. Yang, Y. Luo, L. Jiang et al., "Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells," Immunity & Ageing, 2024.
A. M. Hamsalakshmi, M. Alex, M. Arehally Marappa, "Therapeutic benefits of flavonoids against neuroinflammation: a systematic review," in *Springer*, 2022.
A. D. Calma, N. Pavey, P. Menon, "Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications," Current Opinion in..., 2024.
C. R. Balistreri and R. Monastero, "Neuroinflammation and neurodegenerative diseases: how much do we still not know?," Brain sciences, 2023.
S. K. Chakrabarti et al., "From Immune Sanctuary to Neurological Battlefield: The Role of Neuroimmune Cells," Exploratory Research and …, 2024.
T. Pazina, A. W. MacFarlane IV, L. Bernabei, E. Dulaimi, et al., "Alterations of NK cell phenotype in the disease course of multiple myeloma," Cancers, vol. 13, no. 16, 2021.
M. J. Lee and C. A. Blish, "Defining the role of natural killer cells in COVID-19," Nature immunology, 2023.
S. K. Wyatt-Johnson, R. Afify, and R. R. Brutkiewicz, "The immune system in neurological diseases: what innate-like T cells have to say," *Journal of Allergy and Clinical Immunology*, vol. 2024, Elsevier.
M. Podbielska, T. Ariga, and A. Pokryszko-Dragan, "Sphingolipid players in multiple sclerosis: their influence on the initiation and course of the disease," *International Journal of …*, vol. 2022.
Y. Li, F. Wang, S. Imani, L. Tao et al., "Natural killer cells: friend or foe in metabolic diseases?," Frontiers in Immunology, 2021.
A. Zanghì, P. S. Di Filippo, C. Avolio, et al., "Myeloid-derived Suppressor Cells and Multiple Sclerosis," Current ..., 2025.
A. Bibi, Z. Yu, L. Cui, and G. Yang, "Harnessing monocyte dynamics for treatment of multiple sclerosis; insights from experimental model studies," Immunotherapy Advances, 2025.
D. Deak, N. Gorcea-Andronic, V. Sas, "A narrative review of central nervous system involvement in acute leukemias," Annals of ..., 2021.
S. Garofalo, A. Mormino, L. Mazzarella, G. Cocozza, et al., "Platelets tune fear memory in mice," Cell Reports, 2025.
C. Liu, J. Zhu, Y. Mi, and T. Jin, "Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis," Journal of Neuroinflammation, 2022.
S. Rodríguez Murúa and M. F. Farez, "The immune response in multiple sclerosis," Annual Review of ..., vol. 2022.
C. E. Finger, I. Moreno-Gonzalez, A. Gutierrez, et al., "Age-related immune alterations and cerebrovascular inflammation," *Molecular*, 2022.
G. Beythien, S. Becker, E. Leitzen, "Bridging the gap: Canine in vitro models of the central nervous system as tools to study pathogenetic mechanisms in neurodegenerative disease and …", Veterinary…, 2025.
M. Prinz, T. Masuda, M. A. Wheeler, et al., "Microglia and central nervous system–associated macrophages—from origin to disease modulation," *Annual Review of Immunology*, vol. 39, pp. 251-277, 2021.
M. J. Mansilla and S. Presas-Rodríguez, "Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy," *Cellular & Molecular*, vol. 2021, pp. 1-10, 2021.
S. S. Soldan and P. M. Lieberman, "Epstein–Barr virus and multiple sclerosis," Nature Reviews Microbiology, 2023.
S. K. Sarkar and A. M. L. Willson, "The plasticity of immune cell response complicates dissecting the underlying pathology of multiple sclerosis," Journal of Immunology, vol. 2024, Wiley Online Library.
P. Yan, J. Wang, B. Yue, and X. Wang, "Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma," *Biophysica Acta (BBA)-Reviews on*, vol. 2024, Elsevier.
H. Touil, K. Mounts, and P. L. De Jager, "Differential impact of environmental factors on systemic and localized autoimmunity," Frontiers in immunology, 2023.
C. Bolton, "… linking exposure to environmental stressors and associated alterations in the dynamics of immunosenescence (ISC) with the global increase in multiple sclerosis (MS …," Immunity & Ageing, 2024.
S. Khoshbakht, D. Başkurt, A. Vural, and S. Vural, "Behçet's Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade," *International Journal of …*, 2023.
B. Szmyd, W. Mlynarski, and A. Pastorczak, "Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants," Mutation Research/Reviews in Mutation Research, vol. 2021, Elsevier.
E. González-Madrid and M. A. Rangel-Ramírez, "Risk factors from pregnancy to adulthood in multiple sclerosis outcome," *International Journal of …*, 2022.
S. D. Kumar, "Unveiling the regulation of germinal centre responses and antibody production by follicular T cells," 2022.
J. Zhu, "Trajectories of Cognitive And Neural Maturation in Adolescent Primates," 2024.
H. Ye, "Application of Uncertainty Quantification, Benchmarking, and Model Diagnostic Tools to Inform Climate Risk Assessments," 2023.
T. Sakal, "A mathematical theory of multilevel selection and holobiont evolution," 2023.
T. Hojjatipour, S. Aslani, S. Salimifard, H. Mikaeili, "NK cells-Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases," *International Journal*, vol. 2022, Elsevier.
JF You, CC Lee, YS Lee, YJ Chern, CK Liao, "Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical …", Translational …, 2025.
J. Ding, X. Yan, C. Zhao, D. Zhao, Y. Jia, K. Ren, Y. Wang, "The ratio of circulating CD56dim NK cells to follicular T helper cells as a promising predictor for disease activity of relapsing-remitting multiple sclerosis," Heliyon, 2024.
M. Gascón-Ruiz, A. Ramírez-Labrada, R. Lastra, et al., "A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer," Cancers, 2023.
G. Hamilton and A. Plangger, "The impact of NK cell-based therapeutics for the treatment of lung cancer for biologics: targets and therapy," Biologics: Targets and Therapy, 2021.
A. Ziblat, X. L. R. Iraolagoitia, S. Y. Nuñez, N. I. Torres, et al., "Circulating and tumor-infiltrating NK cells from clear cell renal cell carcinoma patients exhibit a predominantly inhibitory phenotype characterized by overexpression of …," Frontiers in…, 2021.
Z. Lu, Y. Tian, Z. Bai, J. Liu, Y. Zhang, J. Qi, and M. Jin, "Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus," *Research & Therapy*, vol. 2022, Springer.
M. Tenuta, C. Pandozzi, F. Sciarra, F. Campolo, and others, "Circulating natural killer cells as prognostic value for non-small-cell lung cancer patients treated with immune checkpoint inhibitors: correlation with …," Cancers, vol. 2023.
P. Michael, D. Luke, and O. Robinson, "This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience," Frontiers in Psychology, 2023.
S. A. Barker, "Administration of N, N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT," Psychopharmacology, 2022.
L. X. Luan, E. Eckernäs, and M. Ashton, "Psychological and physiological effects of extended DMT," Journal of …, 2024.
E. Frecska and A. Kovacs, "The protective role of dimethyltryptamine and its analogues against ischemia-reperfusion injury: Commentary," Neuroscience, 2021.
D. Cheng, Z. G. Lei, K. Chu, O. J. H. Lam, and C. Y. Chiang, "N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum …," Alzheimer's Research & …, vol. 2024, Springer.
Copyright (c) 2025 Zahraa A Mohammed, Fatima Mallallah Mohammed, Zainab M Qassam, Osama A Mohsein
This work is licensed under a Creative Commons Attribution 4.0 International License.
